This finding aligns with the previous meta-analysis by Chen W et al., which showed that vitamin D supplementation can significantly reduce insulin levels and the result was marked when it was given in a short-term and high dosage to patients with a vitamin D deficiency, who are overweight, or who have an HbA1C of 8% or a higher level [19]. The gene discussed is INS; the disease is vitamin D deficiency.